List view / Grid view
Nemera is a world leader in the design, development and manufacturing of drug delivery devices for the pharmaceutical, biotechnology and generics industries. Nemera always puts patients first, providing high-quality solutions that have a demonstrable impact on patients’ health, including off-the-shelf innovative systems, customized design development and GMP contract manufacturing.
Researchers have developed a series of lipid nanoparticles, which encapsulate RNA, for effective and improved vaccine delivery.
Researchers have developed a chikungunya vaccine that can be stored at warm temperatures and manufactured quickly, which has been validated in animal models.
Health authorities in the Democratic Republic of Congo are planning to use a second vaccine to treat the Ebola virus.
The successful pilot programme could represent an important step forward in biopharmaceutical supply chain innovation.
An influenza vaccine manufacturer has announced it is filing an Annual Strain Update with the US Food and Drug Administration (FDA) in the coming weeks due to advances in influenza vaccine technology.
The Almac Group, a CDMO serving the pharmaceutical and biotech sectors globally, is expanding its Edinburgh Technopole facility to allow scale-up of its personalised cancer vaccine activities...
Chinese police say they have opened an investigation into reports that at least 145 children received an expired polio vaccine...
Nanoparticles could offer a new way to help eradicate the disease worldwide...
New research could serve as the stepping-stone in constructing vaccines with a greater likelihood of finding and attacking...
Researchers aim to develop a new immunotherapy that could alter the immune reactions to food. The result: Extended relief from peanut allergies...
Engineers have developed a miniature, ultra-low power injectable biosensor that could be used for continuous, long-term alcohol monitoring...
Researchers have used kappa-carrageenan and nanosilicates to form injectable hydrogels to promote haemostasis and facilitate wound healing...
Novel vaccine technologies are critical to improving the public health response to infectious disease threats that continually emerge and re-emerge, according to scientists at the NIAID...
Medical researchers point to a promising route for designing an effective vaccine for the respiratory syncytial virus...
